Non-Small Cell Lung Cancer

Study findings on non-small cell lung cancer are outlined in reports from D.H. Lee and colleagues

Published in Cancer Weekly, August 11th, 2009

"Early prediction of treatment response is of great value to avoid unnecessary toxicity of ineffective treatment and to get a chance to receive another effective treatment earlier. We conducted a prospective study to evaluate the role of integrated 18-fluorodeoxyglucose positron emission tomography/computed tomography as a tool for early response predictor," researchers in South Korea report.

"Between May 2004 and November 2005, 31 patients with pathologically proven stage IIIB/IV non-small cell lung cancer participated in this study. Metabolic response was assessed prospectively after one cycle of systemic therapy, which was compared with conventional radiographic...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2009-08-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry